\BOOKMARK [0][-]{section*.4}{Glossary}{}% 1
\BOOKMARK [0][-]{section*.6}{Acronyms}{}% 2
\BOOKMARK [0][-]{chapter*.7}{References}{}% 194
\BOOKMARK [0][-]{appendix.A}{Sample Quality}{}% 195
\BOOKMARK [1][-]{section.A.1}{Sample Correlation}{appendix.A}% 196
\BOOKMARK [1][-]{section.A.2}{Replicate Samples in TCGA Breast}{appendix.A}% 197
\BOOKMARK [0][-]{appendix.B}{Software Used for Thesis}{}% 198
\BOOKMARK [0][-]{appendix.C}{Secondary Screen Data}{}% 199
\BOOKMARK [0][-]{appendix.D}{Mutation Analysis in Breast Cancer}{}% 200
\BOOKMARK [1][-]{section.D.1}{Synthetic Lethal Genes and Pathways}{appendix.D}% 201
\BOOKMARK [1][-]{section.D.2}{Synthetic Lethal Expression Profiles}{appendix.D}% 202
\BOOKMARK [1][-]{section.D.3}{Comparison to Primary Screen}{appendix.D}% 203
\BOOKMARK [2][-]{subsection.D.3.1}{Resampling Analysis}{section.D.3}% 204
\BOOKMARK [1][-]{section.D.4}{Compare SLIPT genes}{appendix.D}% 205
\BOOKMARK [1][-]{section.D.5}{Metagene Analysis}{appendix.D}% 206
\BOOKMARK [1][-]{section.D.6}{Mutation Variation}{appendix.D}% 207
\BOOKMARK [2][-]{subsection.D.6.1}{Mutation Frequency}{section.D.6}% 208
\BOOKMARK [2][-]{subsection.D.6.2}{PI3K Mutation Expression}{section.D.6}% 209
\BOOKMARK [0][-]{appendix.E}{Metagene Expression Profiles}{}% 210
\BOOKMARK [0][-]{appendix.F}{Stomach Expression Analysis}{}% 211
\BOOKMARK [1][-]{section.F.1}{Synthetic Lethal Genes and Pathways}{appendix.F}% 212
\BOOKMARK [1][-]{section.F.2}{Comparison to Primary Screen}{appendix.F}% 213
\BOOKMARK [2][-]{subsection.F.2.1}{Resampling Analysis}{section.F.2}% 214
\BOOKMARK [1][-]{section.F.3}{Metagene Analysis}{appendix.F}% 215
\BOOKMARK [0][-]{appendix.G}{Stomach Mutation Analysis}{}% 216
\BOOKMARK [1][-]{section.G.1}{Synthetic Lethal Genes and Pathways}{appendix.G}% 217
\BOOKMARK [1][-]{section.G.2}{Synthetic Lethal Expression Profiles}{appendix.G}% 218
\BOOKMARK [1][-]{section.G.3}{Comparison to Primary Screen}{appendix.G}% 219
\BOOKMARK [2][-]{subsection.G.3.1}{Resampling Analysis}{section.G.3}% 220
\BOOKMARK [1][-]{section.G.4}{Metagene Analysis}{appendix.G}% 221
\BOOKMARK [0][-]{appendix.H}{Global Synthetic Lethality in Stomach Cancer}{}% 222
\BOOKMARK [1][-]{section.H.1}{Hub Genes}{appendix.H}% 223
\BOOKMARK [1][-]{section.H.2}{Hub Pathways}{appendix.H}% 224
\BOOKMARK [0][-]{appendix.I}{Replication in cell line encyclopaedia}{}% 225
\BOOKMARK [0][-]{appendix.J}{Synthetic Lethal Genes in Pathways}{}% 226
\BOOKMARK [0][-]{appendix.K}{Pathway Connectivity for Mutation SLIPT}{}% 227
\BOOKMARK [0][-]{appendix.L}{Information Centrality for Gene Essentiality}{}% 228
\BOOKMARK [0][-]{appendix.M}{Pathway Structure for Mutation SLIPT}{}% 229
\BOOKMARK [0][-]{appendix.N}{Performance of SLIPT and 2}{}% 230
\BOOKMARK [1][-]{subsection.N.0.1}{Correlated Query Genes affects Specificity}{appendix.N}% 231
\BOOKMARK [0][-]{appendix.O}{Graph Structures}{}% 232
\BOOKMARK [1][-]{section.O.1}{Simulations from Graph Structures}{appendix.O}% 233
\BOOKMARK [1][-]{section.O.2}{Simulations from Inhibiting Graph Structures}{appendix.O}% 234
\BOOKMARK [1][-]{section.O.3}{Simulation across Graph Structures}{appendix.O}% 235
\BOOKMARK [1][-]{section.O.4}{Graph Structure Simulations with 20K genes}{appendix.O}% 236
\BOOKMARK [2][-]{subsection.O.4.1}{Inhibiting Graph Structure Simulations with 20K genes}{section.O.4}% 237
\BOOKMARK [1][-]{section.O.5}{Simations from Pathway Graph Structures}{appendix.O}% 238
